Skip to content

Clinical trials

Recruiting Alzheimer Disease trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Recruiting Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20244
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Bristol-Myers Squibb4
Eidos Therapeutics, a BridgeBio company1
Eisai Co., Ltd.1
Hoffmann-La Roche1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Co., Ltd.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease19
Dementia5
Cognitive Dysfunction4
Brain Diseases2
Nervous System Diseases2
Neurocognitive Disorders2
Neurodegenerative Diseases2
Plaque, Amyloid2
Psychotic Disorders2
Amyloid Neuropathies, Familial1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.